Michiko Feehan

2023-2025

28

U.S. Department of Health and Human Services, U.S. Food and Drug Administration

Gain a deeper understanding of the cultural and technical landscape for innovative medical device development, regulatory review, and commercialization in Japan to tackle mutual goals of fostering innovation, and advancement of international regulatory harmonization and standardization in technologies that facilitate patient access to safe and effective novel devices. Contribute to this important bilateral relationship, further mutual understanding, and support the efforts for a closer U.S.-Japan cooperation on critical challenges.